Comprehensive Cancer Epidemiology

CancerMPact® Patient Metrics module is a Web-based, easy-to-use, comprehensive resource for historical, current, and projected cancer epidemiology and treatment estimates to the year 2030.

Best-in-class information and proprietary calculations provide key data on:

• Incidence (annual new cases of cancer) by stage
• Restaged 10-year prevalence (annual surviving cancer patients from up to 10 years prior that accounts for progression to later stages)
• Active Disease (estimate of eligible patients by stage that does not include early-stage patients in remission)
• Treated patient populations by modality (surgery, radiation, drug therapy, etc.)
• Treated patient populations by drug regimen and by specific agent

Combines our expertise in epidemiology and oncology

Broad coverage combined with deep understanding of the treatment of cancer
Includes analysis of 30 tumor types by country for the U.S., France, Germany, Italy, Spain, the UK, and Japan

Robust and Trustworthy Data Sources
Patient Metrics incorporates the most robust and trustworthy data. Sources include SEER and NODB longitudinal patient data for the United States, regional and organ-specific registries in Japan, and a combination of country-specific registry data and proprietary physician interviews for Western Europe.

Proprietary population modeling and projection methodologies
Uncover new opportunities through illustration of tumor progression and recurrence – not just stage of diagnosis. Active disease is a proprietary metric that describes the treatable patient population at any given point in time – not just those treated. Validation of treated patients is conducted to ensure confidence in data integrity.

Provides insight necessary for improved decision-making

• Evaluating Market Opportunities
• Prioritizing Financial Resources
• Developing Forecasting Estimates

For more information on MattsonJack's oncology services or knowledgeware products, phone: 650.403.7001 or e-mail us at info@mattsonjack.com.